-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Immunome Inc. (IMNM)
-
-
-
-
-
-
-
Goldman Sachs Starts Immunome Inc. (IMNM) at Buy
-
-
-
-
-
-
-
Immunome Inc. (IMNM) Prices Upsized Public Offering of Common Stock at $7.75/Each
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Immunome Inc. (IMNM)
-
-
-
-
416,810 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

